Literature DB >> 29406693

Comprehensive Profiling of Fecal Metabolome of Mice by Integrated Chemical Isotope Labeling-Mass Spectrometry Analysis.

Bi-Feng Yuan1, Quan-Fei Zhu1, Ning Guo1, Shu-Jian Zheng1, Ya-Lan Wang1, Jie Wang2,3, Jing Xu1, Shi-Jie Liu1, Ke He1, Ting Hu2,3, Ying-Wei Zheng2,3, Fu-Qiang Xu2,3,4, Yu-Qi Feng1.   

Abstract

Gut microbiota plays important roles in the host health. The host and symbiotic gut microbiota coproduce a large number of metabolites during the metabolism of food and xenobiotics. The analysis of fecal metabolites can provide a noninvasive manner to study the outcome of the host-gut microbiota interaction. Herein, we reported the comprehensive profiling of fecal metabolome of mice by an integrated chemical isotope labeling combined with liquid chromatography-mass spectrometry (CIL-LC-MS) analysis. The metabolites are categorized into several submetabolomes based on the functional moieties (i.e., carboxyl, carbonyl, amine, and thiol) and then analysis of the individual submetabolome was performed. The combined data from the submetabolome form the metabolome with relatively high coverage. To this end, we synthesized stable isotope labeling reagents to label metabolites with different groups, including carboxyl, carbonyl, amine, and thiol groups. We detected 2302 potential metabolites, among which, 1388 could be positively or putatively identified in feces of mice. We then further confirmed 308 metabolites based on our established library of chemically labeled standards and tandem mass spectrometry analysis. With the identified metabolites in feces of mice, we established mice fecal metabolome database, which can be used to readily identify metabolites from feces of mice. Furthermore, we discovered 211 fecal metabolites exhibited significant difference between Alzheimer's disease (AD) model mice and wild type (WT) mice, which suggests the close correlation between the fecal metabolites and AD pathology and provides new potential biomarkers for the diagnosis of AD.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29406693     DOI: 10.1021/acs.analchem.7b05355

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  10 in total

1.  Chemical Isotope Labeling LC-MS for Metabolomics.

Authors:  Shuang Zhao; Liang Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Evaluation of Untargeted Metabolomic Strategy for the Discovery of Biomarker of Breast Cancer.

Authors:  Xujun Ruan; Yan Wang; Lirong Zhou; Qiuling Zheng; Haiping Hao; Dandan He
Journal:  Front Pharmacol       Date:  2022-05-30       Impact factor: 5.988

3.  Gut microbial involvement in Alzheimer's disease pathogenesis.

Authors:  Yu Zhang; Rulin Geng; Qiuyun Tu
Journal:  Aging (Albany NY)       Date:  2021-05-10       Impact factor: 5.682

Review 4.  Gut Microbiota: Implications in Alzheimer's Disease.

Authors:  Yixi He; Binyin Li; Dingya Sun; Shengdi Chen
Journal:  J Clin Med       Date:  2020-06-29       Impact factor: 4.241

5.  Ratiometric Mass Spectrometry Imaging for Stain-Free Delineation of Ischemic Tissue and Spatial Profiling of Ischemia-Related Molecular Signatures.

Authors:  Zixuan Wang; Ran Yang; Yaxin Zhang; Xiangyi Hui; Liuyan Yan; Ruiping Zhang; Xin Li; Zeper Abliz
Journal:  Front Chem       Date:  2021-12-21       Impact factor: 5.221

6.  Cryptosporidiosis Modulates the Gut Microbiome and Metabolism in a Murine Infection Model.

Authors:  Avinash V Karpe; Melanie L Hutton; Steven J Mileto; Meagan L James; Chris Evans; Rohan M Shah; Amol B Ghodke; Katie E Hillyer; Suzanne S Metcalfe; Jian-Wei Liu; Tom Walsh; Dena Lyras; Enzo A Palombo; David J Beale
Journal:  Metabolites       Date:  2021-06-11

7.  Multi-Solvent Extraction Procedure for the Pioneer Fecal Metabolomic Analysis-Identification of Potential Biomarkers in Stable Kidney Transplant Patients.

Authors:  Soumaya Kouidhi; Nessrine Souai; Muhanad Alhujaily; Oumaima Zidi; Ameni Kochbati; Alaeddine Redissi; Tareg M Belali; Imene El Kossai; Jamelddine El Manaa; Ameur Cherif; Wissem Mnif; Amor Mosbah
Journal:  Diagnostics (Basel)       Date:  2021-05-26

8.  Comprehensive and semi-quantitative analysis of carboxyl-containing metabolites related to gut microbiota on chronic kidney disease using 2-picolylamine isotopic labeling LC-MS/MS.

Authors:  Yoshitomi Kanemitsu; Eikan Mishima; Masamitsu Maekawa; Yotaro Matsumoto; Daisuke Saigusa; Hiroaki Yamaguchi; Jiro Ogura; Hiroki Tsukamoto; Yoshihisa Tomioka; Takaaki Abe; Nariyasu Mano
Journal:  Sci Rep       Date:  2019-12-13       Impact factor: 4.379

9.  Describing the fecal metabolome in cryogenically collected samples from healthy participants.

Authors:  Kajetan Trošt; Linda Ahonen; Tommi Suvitaival; Nina Christiansen; Trine Nielsen; Maja Thiele; Suganya Jacobsen; Aleksander Krag; Peter Rossing; Torben Hansen; Lars Ove Dragsted; Cristina Legido-Quigley
Journal:  Sci Rep       Date:  2020-01-21       Impact factor: 4.379

10.  Qualitative and Quantitative Analysis of Regional Cerebral Free Fatty Acids in Rats Using the Stable Isotope Labeling Liquid Chromatography-Mass Spectrometry Method.

Authors:  Ting Hu; Quanfei Zhu; Yuning Hu; Ghulam Mustafa Kamal; Yuqi Feng; Anne Manyande; Jie Wang; Fuqiang Xu
Journal:  Molecules       Date:  2020-11-06       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.